Please login to the form below

Professor Andy Black joins Lucid Group as non-executive Chairman

Professor Andy Black, an experienced board-level executive for the life sciences industry, has joined Lucid Group as non-executive Chairman of the Board.

Professor Black, co-founder of Kinapse − an international consultancy to the life sciences industry and the winner of six Fast Track awards − is a Professor of Practice at King’s College London, where he teaches entrepreneurship and supports both the university and King’s Health Partners with commercial partnerships.

Professor Black’s extensive pharmaceutical and management experience will help inform Lucid Group’s growth and development strategy, advancing the group towards its vision of bringing together industry-leading capabilities to tackle some of the most challenging healthcare problems through an outcomes-led approach.

Dennis O’Brien, Co-founder and CEO, Lucid Group, commented: “We are delighted to welcome Andy to the Lucid Group as Chairman. His deep industry knowledge, people focus and experience building a strategic consultancy business, make him invaluable in supporting our global development and growth. He is deeply passionate about making a difference to people’s lives which is directly aligned to the Lucid vision.”

Andy Black, Chairman of the Board, Lucid Group, commented: “I am delighted to be taking on the position of Chairman of the Board at Lucid Group. We share the same values and passion for attracting, developing, and retaining the best people to fuel a purpose-driven organisation. I look forward to working closely with our great  team as it continues to build the world’s best healthcare solutions business  and transform patients’ lives around the world.”

For further information about Lucid Group please visit www.wearelucidgroup.com or contact Laura Gaskell via email: laura.gaskell@wearelucidgroup.com or call +44 7557 739 059.

About Lucid Group

Founded in 2007, Lucid Group is a global multi-capability healthcare communications consultancy with core expertise in medical strategy, healthcare communications, creative and brand strategy, motion, digital and technology, behaviour change, metrics, and data analytics.  We partner with the pharma and biotech industry, delivering life transforming value with connected capabilities to create pioneering solutions that change behaviour, improve clinical practice and advance health outcomes.  Transforming lives. Always.

1st October 2021

Share

Tags